To ascertain the potential of PPIH protein as a clinical tumor marker, we conducted an enzyme-linked immunosorbent assay (ELISA) to measure PPIH levels in serum samples from patients with LIHC, COAD, BC, and healthy controls, comprising 16 cases each. The gene discussed is PPIH; the disease is breast cancer.